NovaBay Pharmaceuticals Inc
NBY1.820USD
-0.120-6.19%
終値 09/19, 16:00（ET）15分遅れの株価
10.59M時価総額
4.57直近12ヶ月PER
詳細情報 NovaBay Pharmaceuticals Inc 企業名
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
企業情報
企業コードNBY
会社名NovaBay Pharmaceuticals Inc
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. David E. Lazar
従業員数14
証券種類Ordinary Share
決算期末Oct 26
本社所在地2000 Powell St Ste 1150
都市EMERYVILLE
証券取引所NYSE American Consolidated
国United States of America
郵便番号94608-1804
電話番号15108998800
ウェブサイトhttps://novabay.com/
企業コードNBY
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. David E. Lazar
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. David E. Lazar
Mr. David E. Lazar
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
地域別USD
会社名
収益
比率
United States
9.78M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
他の
79.23%
株主統計
株主統計
比率
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
他の
79.23%
種類
株主統計
比率
Hedge Fund
18.60%
Investment Advisor
1.75%
Investment Advisor/Hedge Fund
0.58%
Venture Capital
0.35%
Individual Investor
0.02%
他の
78.70%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
2023Q1
51
13.02K
22.50%
-2.13K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Poplar Point Capital Management LLC
1.02M
17.54%
+19.91K
+1.99%
Jun 03, 2025
C2C Wealth Management, LLC
55.00K
0.95%
+4.10K
+8.05%
Mar 31, 2025
Geode Capital Management, L.L.C.
35.00K
0.6%
+1.97K
+5.95%
Mar 31, 2025
Two Sigma Investments, LP
17.47K
0.3%
-13.94K
-44.37%
Mar 31, 2025
XTX Markets LLC
19.85K
0.34%
+3.71K
+22.98%
Mar 31, 2025
Tower Research Capital LLC
5.46K
0.09%
+6.00
+0.11%
Mar 31, 2025
UBS Financial Services, Inc.
749.00
0.01%
+749.00
--
Mar 31, 2025
Hall (Justin M)
580.00
0.01%
-2.00
-0.34%
Mar 18, 2025
The Vanguard Group, Inc.
392.00
0.01%
--
--
May 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
日付
種類
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
